Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 6/20 | 0.43 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.43 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.43 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TGM2 | P21980 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | WNT3 | P56703 | 1/20 | 0.39 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.39 |
| ▸ | TRHR | P34981 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fasoracetam SCHEMBL194770 | 0.95 | HPGD (0.47) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| SCHEMBL9735864 | 0.95 | HPGD (0.47) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| Fasoracetam SCHEMBL194771 | 0.95 | HPGD (0.47) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| Fasoracetam SCHEMBL9734362 | 0.95 | HPGD (0.47) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| Fasoracetam SCHEMBL23922653 | 0.95 | HPGD (0.47) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| Fasoracetam SCHEMBL18323021 | 0.93 | HPGD (0.46) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| SCHEMBL9734368 | 0.93 | NAMPT (0.46) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| SCHEMBL5971671 | 0.93 | NAMPT (0.46) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| SCHEMBL9736271 | 0.93 | NAMPT (0.46) | NAMPTTPSAB1TPSD1TPSG1HPGD | |
| SCHEMBL7955572 | 0.88 | NAMPT (0.48) | NAMPTTPSAB1TPSD1TPSG1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112040938-B | Solid forms of fasoracetam | 费城儿童医院 | 2024-06-25 | — | — | CN | disclosed |
| US-20230203001-A1 | SOLID FORMS OF FASORACETAM | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2023-06-29 | — | — | US | disclosed |
| US-11608324-B2 | Solid forms of fasoracetam | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2023-03-21 | — | — | US | disclosed |
| US-20210355102-A1 | Solid Forms of Fasoracetam | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 2021-11-18 | — | — | US | disclosed |
| CN-112040938-A | Solid forms of fasoracetam | 费城儿童医院 | 2020-12-04 | — | — | CN | disclosed |
| EP-3740204-A1 | SOLID FORMS OF FASORACETAM | The Children's Hospital Of Philadelphia (US) | 2020-11-25 | — | — | EP | disclosed |
| WO-2019143824-A1 | SOLID FORMS OF FASORACETAM | AEVI GENOMIC MEDICINE, INC. (US) | 2019-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355102-A1 | Solid Forms of Fasoracetam | FAH, FASN, PFAS | NAMPT 1232/4885TPSAB1 3956/4885TPSD1 4537/4885 |
| US-20230203001-A1 | SOLID FORMS OF FASORACETAM | FAH, FASN, PFAS | NAMPT 1232/4885TPSAB1 3956/4885TPSD1 4537/4885 |
| US-11608324-B2 | Solid forms of fasoracetam | FAH, FASN, PFAS | NAMPT 1232/4885TPSAB1 3956/4885TPSD1 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.